Clinical Trials Browser

Phase 2 × Glioma × Cisplatin × Clear all

Brain Neoplasms, Glioma, Brain Stem Neoplasms

NCT00002608 2013-07-10

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

CNSEndocrineGastrointestinalHead & NeckOther solid neoplasmSarcomaThoracic

Familial ependymoma, Thyroid Cancer, Papillary, Mesothelioma, Malignant, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Medulloblastoma, Oligodendroglioma, Pheochromocytoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Adenocarcinoma, Follicular, Adrenocortical Carcinoma, Carcinoma, Medullary, Glioma, Subependymal, Gliosarcoma, Optic Nerve Glioma, Thyroid Carcinoma, Anaplastic

NCT00014573 2013-04-08

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Phase 2 Completed

CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

NCT01670890 2012-08-22

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

Phase 2 Unknown

120 enrolled

CNS

Glioma

NCT00147160 2012-04-11

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

Phase 2 Completed

87 enrolled

CNS

Glioma

Clinical Trials

Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents